There are several reasons why people invest. However, a principle common to everyone is – “evaluate risk and return”. The guideline: the higher the rate of return, the higher the degree of risk.
Selecta Biosciences, Inc., a biopharmaceutical company developing synthetic nanoparticle vaccines, today announced that it has raised $15 million in a Series C financing round. OrbiMed Advisors LLC led the round, with participation from existing investors Polaris Venture Partners, Flagship Ventures, NanoDimension and Leukon Investments. The Series C financing brings the total capital raised by Selecta [...]
Today is perhaps one of the crucial times where control and psychological factors would be put to the test. If before we had problems with cash and finances, now it is all about knowing where to get them. And if we are not careful, we may just end up looking for means of cash inflow, [...]
Recent Comments